Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different hypoglycemic regimens for newly diagnosed type 2 diabetes
ChiCTR2300076753Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Shantou University Medical College
- Start
- Oct 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of human insulin in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by The First Affiliated Hospital of Shantou University Medical College. Primary endpoints: Fasting blood glucose at 24 weeks, 2-hour plasma glucose at 24 weeks and 2 more. Started Oct 2023; status: recruiting.
02
Drugs
human insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2300076753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076753.